Serum Vitamin D in Patients with Chronic Obstructive Lung Disease Does Not Correlate with Mortality - Results from a 10-Year Prospective Cohort Study

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Holmgaard, Dennis Back ^a   Mygind, Lone Hagens ^b   Titlestad, Ingrid Louise ^a   Madsen, Hanne ^a   Fruekilde, Palle Bach Nielsen ^a   Pedersen, Svend Stenvang ^a   Pedersen, C ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; VITAMIN D;

ADULT; AGED; ARTICLE; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY FLOW; FORCED EXPIRATORY VOLUME; HAZARD RATIO; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUTROPHIL COUNT; OUTCOME ASSESSMENT; PREVALENCE; PROGNOSIS; SCORING SYSTEM; SEASONAL VARIATION; SMOKING; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

AGED; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; VITAMIN D;

EID: 84872353286     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0053670     Document Type: Article

References (38)

1. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS, (2001) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 163: 1256-1276.
2. Lash TL, Johansen MB, Christensen S, Baron JA, Rothman KJ, et al. (2011) Hospitalization rates and survival associated with COPD: a nationwide Danish cohort study. Lung 189: 27-35.
3. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ, (2006) Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 367: 1747-1757.
4. Pauwels RA, Rabe KF, (2004) Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet 364: 613-620.
5. Sandford AJ, Chagani T, Weir TD, Connett JE, Anthonisen NR, et al. (2001) Susceptibility genes for rapid decline of lung function in the lung health study. Am J Respir Crit Care Med 163: 469-473.
6. Kunisaki KM, Niewoehner DE, Singh RJ, Connett JE, (2011) Vitamin D status and longitudinal lung function decline in the Lung Health Study. Eur Respir J 37: 238-243.
7. Molfino NA, (2007) Genetic predisposition to accelerated decline of lung function in COPD. Int J Chron Obstruct Pulmon Dis 2: 117-119.
8. Nishimura M, Makita H, Nagai K, Konno S, Nasuhara Y, et al. (2011) Annual Change in Pulmonary Function and Clinical Phenotype in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med.
9. Holick MF, (2003) Vitamin D: A millenium perspective. J Cell Biochem 88: 296-307.
10. Hansdottir S, Monick MM, Hinde SL, Lovan N, Look DC, et al. (2008) Respiratory epithelial cells convert inactive vitamin D to its active form: potential effects on host defense. J Immunol 181: 7090-7099.
11. Sigmundsdottir H, Pan J, Debes GF, Alt C, Habtezion A, et al. (2007) DCs metabolize sunlight-induced vitamin D3 to 'program' T cell attraction to the epidermal chemokine CCL27. Nat Immunol 8: 285-293.
12. Kreutz M, Andreesen R, Krause SW, Szabo A, Ritz E, et al. (1993) 1,25-dihydroxyvitamin D3 production and vitamin D3 receptor expression are developmentally regulated during differentiation of human monocytes into macrophages. Blood 82: 1300-1307.
13. Chen S, Sims GP, Chen XX, Gu YY, Lipsky PE, (2007) Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol 179: 1634-1647.
14. Lemire JM, Adams JS, Sakai R, Jordan SC, (1984) 1 alpha,25-dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells. J Clin Invest 74: 657-661.
15. Rigby WF, Stacy T, Fanger MW, (1984) Inhibition of T lymphocyte mitogenesis by 1,25-dihydroxyvitamin D3 (calcitriol). J Clin Invest 74: 1451-1455.
16. Mora JR, Iwata M, von Andrian UH, (2008) Vitamin effects on the immune system: vitamins A and D take centre stage. Nat Rev Immunol 8: 685-698.
17. Haroon M, Fitzgerald O (2011) Vitamin D and its emerging role in immunopathology. Clin Rheumatol.
18. Garland CF, Garland FC, Gorham ED, Lipkin M, Newmark H, et al. (2006) The role of vitamin D in cancer prevention. Am J Public Health 96: 252-261.
19. Koli K, Keski-Oja J, (2000) 1alpha,25-dihydroxyvitamin D3 and its analogues down-regulate cell invasion-associated proteases in cultured malignant cells. Cell Growth Differ 11: 221-229.
20. Dobak J, Grzybowski J, Liu FT, Landon B, Dobke M, (1994) 1,25-Dihydroxyvitamin D3 increases collagen production in dermal fibroblasts. J Dermatol Sci 8: 18-24.
21. Ginde AA, Mansbach JM, Camargo CA Jr, (2009) Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch Intern Med 169: 384-390.
22. Laaksi I, Ruohola JP, Tuohimaa P, Auvinen A, Haataja R, et al. (2007) An association of serum vitamin D concentrations <40 nmol/L with acute respiratory tract infection in young Finnish men. Am J Clin Nutr 86: 714-717.
23. Holick MF, Chen TC, (2008) Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr 87: 1080S-1086S.
24. Janssens W, Bouillon R, Claes B, Carremans C, Lehouck A, et al. (2010) Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene. Thorax 65: 215-220.
25. Black PN, Scragg R, (2005) Relationship between serum 25-hydroxyvitamin d and pulmonary function in the third national health and nutrition examination survey. Chest 128: 3792-3798.
26. Kunisaki KM, Niewoehner DE, Connett JE (2011) Vitamin D Levels and Risk of Acute Exacerbations of Chronic Obstructive Pulmonary Disease: a Prospective Cohort Study. Am J Respir Crit Care Med.
27. Lehouck A, Mathieu C, Carremans C, Baeke F, Verhaegen J, et al. (2012) High doses of vitamin d to reduce exacerbations in chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med 156: 105-114.
28. Celli BR, MacNee W, (2004) Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 23: 932-946.
29. Landbo C, Prescott E, Lange P, Vestbo J, Almdal TP, (1999) Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 160: 1856-1861.
30. Quint JK, Wedzicha JA, (2007) The neutrophil in chronic obstructive pulmonary disease. J Allergy Clin Immunol 119: 1065-1071.
31. Noguera A, Batle S, Miralles C, Iglesias J, Busquets X, et al. (2001) Enhanced neutrophil response in chronic obstructive pulmonary disease. Thorax 56: 432-437.
32. Zerwekh JE, (2008) Blood biomarkers of vitamin D status. Am J Clin Nutr 87: 1087S-1091S.
33. Webb AR, Kline L, Holick MF, (1988) Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. J Clin Endocrinol Metab 67: 373-378.
34. Grimnes G, Almaas B, Eggen AE, Emaus N, Figenschau Y, et al. (2010) Effect of smoking on the serum levels of 25-hydroxyvitamin D depends on the assay employed. Eur J Endocrinol 163: 339-348.
35. Jordan JG Jr, Mann JR, (2010) Obesity and mortality in persons with obstructive lung disease using data from the NHANES III. South Med J 103: 323-330.
36. Peduzzi P, Concato J, Feinstein AR, Holford TR, (1995) Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates. J Clin Epidemiol 48: 1503-1510.
37. Durup D, Jorgensen HL, Christensen J, Schwarz P, Heegaard AM, et al. (2012) A Reverse J-Shaped Association of All-Cause Mortality with Serum 25-Hydroxyvitamin D in General Practice: The CopD Study. J Clin Endocrinol Metab 97: 2644-2652.
38. Ginde AA, Scragg R, Schwartz RS, Camargo CA Jr, (2009) Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults. J Am Geriatr Soc 57: 1595-1603.